Ling Yang

1.6k total citations · 1 hit paper
57 papers, 1.1k citations indexed

About

Ling Yang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ling Yang has authored 57 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ling Yang's work include Lung Cancer Treatments and Mutations (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and COVID-19 Clinical Research Studies (4 papers). Ling Yang is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and COVID-19 Clinical Research Studies (4 papers). Ling Yang collaborates with scholars based in China, United States and United Kingdom. Ling Yang's co-authors include Yuyang Cai, Zhaohui Su, Dean McDonnell, Xiaoshan Li, Yu‐Tao Xiang, Junaid Aḥmad, Ali Cheshmehzangi, Jun Wen, Jaffar Abbas and Metin Kozak and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Ling Yang

53 papers receiving 1.1k citations

Hit Papers

Mental health consequences of COVID-19 media coverage: th... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Yang China 17 192 163 160 152 146 57 1.1k
Ji‐Yeon Kim South Korea 20 208 1.1× 131 0.8× 186 1.2× 108 0.7× 47 0.3× 67 1.4k
Stefano Marchetti Italy 19 54 0.3× 96 0.6× 86 0.5× 91 0.6× 37 0.3× 85 1.2k
Wei Hua China 26 133 0.7× 351 2.2× 69 0.4× 102 0.7× 117 0.8× 264 3.2k
Yuyang Cai China 16 231 1.2× 230 1.4× 77 0.5× 69 0.5× 35 0.2× 43 1.0k
Anant Kumar India 21 454 2.4× 185 1.1× 67 0.4× 192 1.3× 60 0.4× 103 1.8k
Yu Cheng China 23 87 0.5× 169 1.0× 393 2.5× 259 1.7× 71 0.5× 73 1.3k
Peter Hughes United Kingdom 14 185 1.0× 79 0.5× 201 1.3× 198 1.3× 88 0.6× 70 1.0k
Maysa Al‐Hussaini Jordan 21 90 0.5× 75 0.5× 363 2.3× 369 2.4× 141 1.0× 173 1.9k
Andreas Krause Germany 21 67 0.3× 106 0.7× 67 0.4× 219 1.4× 76 0.5× 134 2.5k
Andrea Jonas United States 6 76 0.4× 35 0.2× 176 1.1× 79 0.5× 66 0.5× 12 1.1k

Countries citing papers authored by Ling Yang

Since Specialization
Citations

This map shows the geographic impact of Ling Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Yang more than expected).

Fields of papers citing papers by Ling Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Yang. The network helps show where Ling Yang may publish in the future.

Co-authorship network of co-authors of Ling Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Yang. A scholar is included among the top collaborators of Ling Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Yang. Ling Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Qi, Yi‐Long Wu, Lihua Wu, et al.. (2024). 642P Phase I study of SHR-A2009, a HER3-targeted ADC, in pretreated EGFR-mutated NSCLC. Annals of Oncology. 35. S509–S509. 2 indexed citations
2.
Chang, Yen‐Chiang, et al.. (2024). The legal basis for Chinese vessels navigating in the South China Sea. Marine Policy. 165. 106229–106229. 2 indexed citations
3.
Doi, Toshihiko, et al.. (2024). O7-4 A phase 1 study of zanidatamab monotherapy in Japanese patients with metastatic or unresectable HER2-expressing cancers. Annals of Oncology. 35. S1318–S1319. 1 indexed citations
4.
Yang, Ling, et al.. (2024). News media in crisis: a sentiment and emotion analysis of US news articles on unemployment in the COVID-19 pandemic. Humanities and Social Sciences Communications. 11(1). 1 indexed citations
5.
Yang, Ling, et al.. (2023). Development of biomimetic hexapeptide functionalized monolithic material for capillary microextraction of microcystins in environmental waters. Microchemical Journal. 192. 108942–108942. 1 indexed citations
6.
Yang, Ling. (2023). The Impact of Intelligent Manufacturing on Company Investment Efficiency. Highlights in Business Economics and Management. 9. 649–657.
7.
Zeng, Wu, et al.. (2023). COVID-19 vaccination coverage and its cognitive determinants among older adults in Shanghai, China, during the COVID-19 epidemic. Frontiers in Public Health. 11. 1163616–1163616. 6 indexed citations
8.
Lu, Weiwei, Xiaopan Li, Yichen Chen, et al.. (2022). Long-term Changes in the Premature Death Rate in Lung Cancer in a Developed Region of China: Population-based Study. JMIR Public Health and Surveillance. 8(4). e33633–e33633. 8 indexed citations
9.
Wang, Guodong, Ling Yang, Libin Jiang, et al.. (2022). A new class of quaternary ammonium compounds as potent and environmental friendly disinfectants. Journal of Cleaner Production. 379. 134632–134632. 23 indexed citations
10.
Li, Ling, et al.. (2022). Risk perception and mental health among college students in China during the COVID-19 pandemic: A moderated mediation model. Frontiers in Psychiatry. 13. 955093–955093. 7 indexed citations
11.
Wang, Dandan, Xing‐Kai Qian, Hongxin Li, et al.. (2021). Sensing and imaging of exosomal CD26 secreted from cancer cells and 3D colorectal tumor model using a novel near-infrared fluorogenic probe. Materials Science and Engineering C. 130. 112472–112472. 11 indexed citations
12.
Huang, Chunmei, Xinjie Xu, Yuyang Cai, et al.. (2020). Mining the Characteristics of COVID-19 Patients in China: Analysis of Social Media Posts. Journal of Medical Internet Research. 22(5). e19087–e19087. 58 indexed citations
13.
Li, Xiaopan, Chen Ji, Min Hou, et al.. (2020). Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19. Respiratory Research. 21(1). 169–169. 119 indexed citations
14.
Lu, Weiwei, Yanping Tang, Xiaopan Li, et al.. (2020). Identification of COVID-19 Clinical Phenotypes by Principal Component Analysis-Based Cluster Analysis. Frontiers in Medicine. 7. 570614–570614. 24 indexed citations
15.
Yang, Ling, Mo Zhu, Xinxing Ma, & Chunhong Hu. (2017). USP11 promotes tumorigenesis and enhances MRI detection in breast cancer. Translational Cancer Research. 6(1). 218–227. 1 indexed citations
16.
Yang, Ling, et al.. (2017). The injury,reversibility and intervention strategies of inhibitory control for methamphetamine users. Advances in Psychological Science. 25(10). 1769–1769. 2 indexed citations
17.
Yang, Ling, et al.. (2013). Oxidative stress status in umbilical cord blood from neonates born to mothers with atopic asthma. The Journal of Maternal-Fetal & Neonatal Medicine. 27(2). 192–196. 5 indexed citations
18.
Chen, Yanbin, Ling Yang, Feng Wei, et al.. (2010). Angiosarcoma of the lung: 2 cases report and literature reviewed. Lung Cancer. 70(3). 352–356. 31 indexed citations
19.
Yang, Ling. (2009). Analysis of evolutionary characteristics of space-time of regional high-tech industry competitiveness in China. Kexuexue yanjiu.
20.
Shears, Stephen B., Ling Yang, & Xun Qian. (2004). Cell signaling by a physiologically reversible inositol phosphate kinase/phosphatase. Advances in Enzyme Regulation. 44(1). 265–277. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026